PATENT CLAIM ANALYSIS

Application Number: 15777700
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "679000"]

Abstract:
The combination of curcumin and resveratrol can prevent the microglia from participating in the inflammation pathway in the brain. Thus this combination can reduce/prevent inflammation in the brain secondary to conditions such as obesity, diabetes, injury, and infection. The combination can also reduce chronic pain.

Claim (Index 3):
The use of a combination of resveratrol and curcumin in combination to reduce or prevent inflammation of the brain and neural system in a person experiencing or at risk of any of the following conditions: Inflammation secondary to diabetes,\n Inflammation secondary to obesity, Inflammation as a result of low level trauma to the brain, Inflammation as a result of a low grade fever or infection, Inflammation secondary to hypertension and Chronic pain.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11789583', '14449599', '11478073', '15499440', '13912844']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6815239233866146
- 35 USC 102 Novelty (BERT): 0.4879128256603339
- Combined Prediction Score: 0.6621628136139865
- Mean Citation Score: 166.35254
- Max Citation Score: 172.91593999999995
- Similarity Product: 118.93674543665644

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test